Christopher Taylor | VP, IR |
David Mauney | President |
Laurence Cooper | CEO & Director |
Reni Benjamin | Raymond James & Associates |
Eric Joseph | JPMorgan Chase & Co. |
Swayampakula Ramakanth | H.C. Wainwright & Co. |
I-Eh Jen | Laidlaw & Company |
Thomas Flaten | Lake Street Capital Markets |
Good afternoon, ladies and gentlemen, and welcome to the Ziopharm Oncology First Quarter 2019 Results Call. [Operator Instructions]. I would now like to turn the conference over to your host, Mr. Chris Taylor, Vice President, Investor Relations, Corporate Communications. Sir, you may begin.